The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of Melan-Α/Μart-1-peptide vaccination plus IMP321 on antitumor immunity and clinical benefit in patients receiving autologous PBMCs after lymphodepletion.
Emanuela Romano
Research Funding - Fond'Action
Helene Bichat
No relevant relationships to disclose
Athina Stravodimou
No relevant relationships to disclose
Pedro Romero
No relevant relationships to disclose
Speiser E Daniel
No relevant relationships to disclose
Frederic Triebel
Employment or Leadership Position - Immutep
Stock Ownership - Immutep
Olivier Michielin
No relevant relationships to disclose
Alexander Harari
No relevant relationships to disclose
Serge Leyvraz
No relevant relationships to disclose